Retrospective analysis of adjuvant chemotherapy for curatively resected gastric cancer

Figure 1 Kaplan-Meier curves of disease-free survival (A) and overall survival (B) in Arm A and Arm S. P-value by Log-rank test. A: Disease-free survival (DFS): 41.5 mo vs 24.4 mo, P = 0.007; B: Overall survival: 63.0 mo vs 42.9 mo, P = 0.001.

Figure 2 Kaplan-Meier curves of disease-free survival (A) and overall survival (B) in patients with monotherapy switched or not. P-value by Log-rank test. A: Disease-free survival: Not reached vs 25.4 mo, P = 0.000; B: Overall survival: Not reached vs 49.4 mo, P = 0.005.

Figure 3 Kaplan-Meier curves of disease-free survival (A) and overall survival (B) in patients treated with ≥ 8 cycles or not. P-value by Log-rank test. A: Disease-free survival: Not reached vs 25.8 mo, P = 0.001; B: Overall survival: Not reached vs 56.1 mo, P = 0.002.